Flerie AB
FLERIE | ST
Overview
Corporate Details
- ISIN(s):
- SE0022447348
- LEI:
- 54930047C4A74IBXR037
- Country:
- Sweden
- Address:
- BERZELIUS VÄG 13, 171 65 Solna
- Website:
- https://www.flerie.com/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations. Flerie was established in 2011 by Thomas Eldered, who co-founded and built one of the global top five drug manufacturers, Recipharm. Dr Carl-Johan Spak, now Senior Advisor, and Thomas laid the foundation for Flerie’s evergreen strategy and oversaw the early investments. Flerie sold Cormorant Pharmaceuticals to BMS in 2016 and Cobra Biologics to Cognate Bioservices in early 2020 – this enabled further investments. In 2018, Dr Ted Fjällman, then chief executive of one of the portfolio companies, joined as Venture Partner, later Partner and CEO of Flerie.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-16 10:00 |
Takeover Announcement Report
Flerie AB's subsidiary Flerie Invest AB publish the offer document for the mand…
|
English | 47.2 KB | |
| 2025-06-16 10:00 |
Takeover Announcement Report
Flerie AB:s dotterbolag Flerie Invest AB offentliggör erbjudandehandling avseen…
|
Swedish | 48.3 KB | |
| 2025-06-04 08:00 |
Net Asset Value(s)
SUBSTANSVÄRDE – 31 maj 2025
|
Swedish | 43.5 KB | |
| 2025-06-04 08:00 |
Net Asset Value(s)
NET ASSET VALUE – 31 May 2025
|
English | 43.0 KB | |
| 2025-05-23 07:30 |
Takeover Announcement Report
Flerie Invest AB lämnar ett kontant budpliktsbud till aktieägarna Nanologica AB…
|
Swedish | 62.8 KB | |
| 2025-05-23 07:30 |
Takeover Announcement Report
Flerie Invest AB announces a mandatory cash offer to the shareholders of Nanolo…
|
English | 61.6 KB | |
| 2025-05-14 14:00 |
Regulatory News Service
The General Meetings of Flerie and Toleranzia respectively have approved the me…
|
English | 52.1 KB | |
| 2025-05-14 14:00 |
Regulatory News Service
Bolagsstämmorna i Flerie respektive Toleranzia har godkänt fusionsplanen och bo…
|
Swedish | 44.7 KB | |
| 2025-05-14 12:30 |
Regulatory News Service
Stämmokommuniké från årsstämma i Flerie AB (publ) den 14 maj 2025
|
Swedish | 35.6 KB | |
| 2025-05-14 12:30 |
Regulatory News Service
Bulletin from the Annual General Meeting of Flerie AB (publ) on 14 May 2025
|
English | 35.9 KB | |
| 2025-05-07 08:00 |
Regulatory News Service
SUBSTANSVÄRDE – 30 april 2025
|
Swedish | 43.5 KB | |
| 2025-05-07 08:00 |
Regulatory News Service
NET ASSET VALUE – 30 April 2025
|
English | 42.9 KB | |
| 2025-04-30 18:30 |
Regulatory News Service
Flerie erhåller FDI-godkännande avseende fusionen med Toleranzia
|
Swedish | 46.1 KB | |
| 2025-04-30 18:30 |
Regulatory News Service
Flerie receives FDI-approval for the merger with Toleranzia
|
English | 52.8 KB | |
| 2025-04-25 19:15 |
Takeover Announcement Report
Flerie has increased its holding in Nanologica, whereby an obligation to make a…
|
English | 31.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
RELIEF Therapeutics Holding AG | Switzerland | RLF | |
|
Replek AD | North Macedonia | REPL | |
|
Roche Holding AG | Switzerland | RO | |
|
Ropharma S.A. | Romania | RPH | |
|
RYVU Therapeutics S.A. | Poland | RVU | |
|
Sano Bruno's Enterprises Ltd. | Israel | SANO1 | |
|
Sanofi | France | SAN | |
|
Santhera Pharmaceuticals Holding AG | Switzerland | SANN | |
|
Schott Pharma | Germany | 1SXP | |
|
Sedana Medical | Sweden | SEDANA |